Bill

Bill > HF3595


MN HF3595

MN HF3595
Cannabinoid product regulation provided, sale of cannabinoid containing products limited to individuals 21 years of age or older, cannabinoid product labeling required to contain a barcode or matrix barcode, additional requirements provided for edible cannabinoid products, food definition modified, and cannabinoid containing products that meet regulation requirements established as not controlled substances.


summary

Introduced
02/17/2022
In Committee
03/30/2022
Crossed Over
Passed
Dead
05/23/2022

Introduced Session

92nd Legislature 2021-2022

Bill Summary

A bill for an act relating to health; providing for the regulation of certain products containing cannabinoids; limiting the sale of products containing cannabinoids to individuals 21 years of age or older; requiring labeling of cannabinoid products to contain a barcode or matrix barcode; providing additional requirements for edible cannabinoid products; modifying definition of food; establishing that products containing cannabinoids that meet the regulation requirements are not controlled substances; amending Minnesota Statutes 2020, sections 34A.01, subdivision 4; 151.72, subdivisions 1, 2, 3, 4, 6, by adding a subdivision; 152.02, subdivision 2; Minnesota Statutes 2021 Supplement, section 151.72, subdivision 5.

AI Summary

This bill: - Provides for the regulation of certain products containing cannabinoids, including edible cannabinoid products. - Limits the sale of products containing cannabinoids to individuals 21 years of age or older. - Requires labeling of cannabinoid products to contain a barcode or matrix barcode. - Provides additional requirements for edible cannabinoid products, including restrictions on the appearance, packaging, and THC content. - Modifies the definition of food to exclude edible cannabinoid products. - Establishes that products containing cannabinoids that meet the regulation requirements are not controlled substances under state law. The bill amends several sections of Minnesota Statutes related to the regulation of cannabinoid products, including definitions, scope, testing and labeling requirements, and the classification of these products as controlled substances.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (3)

Last Action

Committee report, to adopt as amended and re-refer to Health Finance and Policy (on 03/30/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...